Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia
Status:
Completed
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
Schizophrenia patients with anti-psychotics have decreased psychiatric symptoms, but have
increased the generation of overweight or obesity. There is correlation between obesity,
diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and cardiovascular
disorders. Cassia seed is one of traditional Chinese herbs, that can decline blood lipedema
effect. Therefore, the purpose of the present study was to design a randomized, double blind,
control group study to assess the therapeutic effect of Cassia seed in schizophrenia patients
with obesity.